Android app Apple app link

Akoustis Technologies, Inc. (AKTS) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$18.26
Day's range
$19.51

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
08/19/2026 Wedbush David Nierengarten $35.00 $25.00   40%
08/18/2026 BMO Capital David Lebowitz $37.00 $25.00   48%
06/15/2026 Raymond James Christopher Raymond $40.00 $20.69   93.33%
06/02/2026 H.C. Wainwright Robert Burns $35.00 $19.61   78.48%

Aktis Oncology Inc FAQ's

Aktis Oncology Inc has been rated by research analysts at Wedbush, BMO Capital, Raymond James, H.C. Wainwright, Leerink Partners in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.